Skip to main content

Table 1 The role and underlying regulatory mechanisms of miRNAs in the pathogenesis of hepatic fibrosis in schistosomiasis

From: The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis

Function

Type

Target

Mechanism/pathway

References

Pro-fibrosis

miR-21, miR-96

Smad7

SMAD signaling pathway

[40, 41]

miR-351

VDR

SMAD and IFN-γ signaling pathway

[45]

miR-146a/b

STAT1

Regulates the transformation of macrophages from M1 to M2/IFN-γ signaling pathway

[46]

miR-27b

PPARγ

Enhances the activation of hepatic stellate cells

[89]

Anti-fibrosis

miR-203-3p

IL-33/Smad3

IL-33/IL-13 pathway

[67, 70]

let-7b

TβRI

TGF-β/SMAD signaling pathway

[80]

miR-182

unknown

Preserves Tregs stability and suppressor function

[88]

miR-15b, miR-16

Bcl2

Caspase signaling pathway

[90]

miR-454

Smad4

SMAD signaling pathway

[91]

miR-155

FOXO3a

ERK1 signaling pathway, EMT process

[92, 93]

miR-29b-3p

COL1A1, COL3A1

TGF-β signaling pathway

[94]

miR-92a-2-5p

TLR2

Promotes NIH-3T3 cell apoptosis

[95]